Search for "dichloro-" in Full Text gives 181 result(s) in Beilstein Journal of Organic Chemistry.
Beilstein J. Org. Chem. 2012, 8, 1936–1998, doi:10.3762/bjoc.8.225
Graphical Abstract
Figure 1: Loschmidt’s structure proposal for benzene (1) (Scheme 181 from [3]) and the corresponding modern stru...
Figure 2: The first isolated bisallenes.
Figure 3: Carbon skeletons of selected bisallenes discussed in this review.
Scheme 1: The preparation of 1,2,4,5-hexatetraene (2).
Scheme 2: The preparation of a conjugated bisallene by the DMS-protocol.
Scheme 3: Preparation of the 3-deuterio- and 3,4-dideuterio derivatives of 24.
Scheme 4: A versatile method to prepare alkylated conjugated bisallenes and other allenes.
Scheme 5: A preparation of 3,4-dimethyl-1,2,4,5-hexatetraene (38).
Scheme 6: A (C6 + 0)-approach to 1,2,4,5-hexatetraene (2).
Scheme 7: The preparation of a fully alkylated bisallenes from a 2,4-hexadiyne-1,6-diol diacetate.
Scheme 8: The preparation of the first phenyl-substituted conjugated bisallenes 3 and 4.
Scheme 9: Selective hydrogenation of [5]cumulenes to conjugated bisallenes: another (C6 + 0)-route.
Scheme 10: Aryl-substituted conjugated bisallenes by a (C3 + C3)-approach.
Scheme 11: Hexaphenyl-1,2,4,5-hexatetraene (59) by a (C3 + C3)-approach.
Scheme 12: An allenation route to conjugated bisallenes.
Scheme 13: The preparation of 3,4-difunctionalized conjugated bisallenes.
Scheme 14: Problems during the preparation of sulfur-substituted conjugated bisallenes.
Scheme 15: The preparation of 3,4-dibromo bisallenes.
Scheme 16: Generation of allenolates by an oxy-Cope rearrangement.
Scheme 17: A linear trimerization of alkynes to conjugated bisallenes: a (C2 + C2 + C2)-protocol.
Scheme 18: Preparation of a TMS-substituted conjugated bisallene by a C3-dimerization route.
Scheme 19: A bis(trimethylsilyl)bisallene by a C3-coupling protocol.
Scheme 20: The rearrangement of highly substituted benzene derivatives into their conjugated bisallenic isomer...
Scheme 21: From fully substituted benzene derivatives to fully substituted bisallenes.
Scheme 22: From a bicyclopropenyl to a conjugated bisallene derivative.
Scheme 23: The conversion of a bismethylenecyclobutene into a conjugated bisallene.
Scheme 24: The preparation of monofunctionalized bisallenes.
Scheme 25: Preparation of bisallene diols and their cyclization to dihydrofurans.
Scheme 26: A 3,4-difunctionalized conjugated bisallene by a C3-coupling process.
Scheme 27: Preparation of a bisallenic diketone by a coupling reaction.
Scheme 28: Sulfur and selenium-substituted bisallenes by a [2.3]sigmatropic rearrangement.
Scheme 29: The biallenylation of azetidinones.
Scheme 30: The preparation of a fully ferrocenylated conjugated bisallene.
Scheme 31: The first isomerization of a 1,5-hexadiyne to a 1,2,4,5-hexatetraene.
Scheme 32: The preparation of alkynyl-substituted bisallenes by a C3-dimerization protocol.
Scheme 33: Preparation of another completely ferrocenylated bisallene.
Scheme 34: The cyclization of 1,5-hexadiyne (129) to 3,4-bismethylenecyclobutene (130) via 1,2,4,5-hexatetraen...
Scheme 35: Stereochemistry of the thermal cyclization of bisallenes to bismethylenecyclobutenes.
Scheme 36: Bisallene→bismethylenecyclobutene ring closures in the solid state.
Scheme 37: A bisallene cyclization/dimerization reaction.
Scheme 38: A selection of Diels–Alder additions of 1,2,4,5-hexatetraene with various double-bond dienophiles.
Scheme 39: The stereochemistry of the [2 + 4] cycloaddition to conjugated bisallenes.
Scheme 40: Preparation of azetidinone derivatives from conjugated bisallenes.
Scheme 41: Cycloaddition of heterodienophiles to a conjugated bisallene.
Scheme 42: Addition of triple-bond dienophiles to conjugated bisallenes.
Scheme 43: Sulfur dioxide addition to conjugated bisallenes.
Scheme 44: The addition of a germylene to a conjugated bisallene.
Scheme 45: Trapping of conjugated bisallenes with phosphinidenes.
Scheme 46: The cyclopropanantion of 1,2,4,5-hexatetraene (2).
Scheme 47: Photochemical reactions involving conjugated bisallenes.
Scheme 48: Base-catalyzed isomerizations of conjugated bisallenes.
Scheme 49: Ionic additions to a conjugated bisallene.
Scheme 50: Oxidation reactions of a conjugated bisallene.
Scheme 51: The mechanism of oxidation of the bisallene 24.
Scheme 52: CuCl-catalyzed cyclization of 1,2,4,5-hexatetraene (2).
Scheme 53: The conversion of conjugated bisallenes into cyclopentenones.
Scheme 54: Oligomerization of a conjugated bisallene by nickel catalysts.
Scheme 55: Generation of 1,2,5,6-heptatetraene (229) as a reaction intermediate.
Scheme 56: The preparation of a stable derivative of 1,2,5,6-heptatetraene.
Scheme 57: A bisallene with a carbonyl group as a spacer element.
Scheme 58: The first preparation of 1,2,6,7-octatetraene (242).
Scheme 59: Preparation of 1,2,6,7-octatetraenes by (C4 + C4)-coupling of enynes.
Scheme 60: Preparation of 1,2,6,7-octatetraenes by (C4 + C4)-coupling of homoallenyl bromides.
Scheme 61: Preparation of 1,2,6,7-octatetraenes by alkylation of propargylic substrates.
Scheme 62: Preparation of two highly functionalized 1,2,6,7-octatetraenes.
Scheme 63: Preparation of several higher α,ω-bisallenes.
Scheme 64: Preparation of different alkyl derivatives of α,ω-bisallenes.
Scheme 65: The preparation of functionalized 1,2,7,8-nonatetraene derivatives.
Scheme 66: Preparation of functionalized α,ω-bisallenes.
Scheme 67: The preparation of an α,ω-bisallene by direct homologation of an α,ω-bisalkyne.
Scheme 68: The gas-phase pyrolysis of 4,4-dimethyl-1,2,5,6-heptatetraene (237).
Scheme 69: Gas-phase pyrolysis of 1,2,6,7-octatetraene (242).
Scheme 70: The cyclopropanation of 1,2,6,7-octatetraene (242).
Scheme 71: Intramolecular cyclization of 1,2,6,7-octatetraene derivatives.
Scheme 72: The gas-phase pyrolysis of 1,2,7,8-nonatetraene (265) and 1,2,8,9-decatetraene (266).
Scheme 73: Rh-catalyzed cyclization of a functionalized 1,2,7,8-nonatetraene.
Scheme 74: A triple cyclization involving two different allenic substrates.
Scheme 75: Bicyclization of keto derivatives of 1,2,7,8-nonatetraene.
Scheme 76: The preparation of complex organic compounds from functionalized bisallenes.
Scheme 77: Cycloisomerization of an α,ω-bisallene containing a C9 tether.
Scheme 78: Organoborane polymers from α,ω-bisallenes.
Scheme 79: Preparation of trans- (337) and cis-1,2,4,6,7-octapentaene (341).
Scheme 80: The preparation of 4-methylene-1,2,5,6-heptatetraene (349).
Scheme 81: The preparation of acetylenic bisallenes.
Scheme 82: The preparation of derivatives of hydrocarbon 351.
Scheme 83: The construction of macrocyclic alleno-acetylenes.
Scheme 84: Preparation and reactions of 4,5-bismethylene-1,2,6,7-octatetraene (365).
Scheme 85: Preparation of 1,2-bis(propadienyl)benzene (370).
Scheme 86: The preparation of 1,4-bis(propadienyl)benzene (376).
Scheme 87: The preparation of aromatic and heteroaromatic bisallenes by metal-mediated coupling reactions.
Scheme 88: Double cyclization of an aromatic bisallene.
Scheme 89: Preparation of an allenic [15]paracyclophane by a ring-closing metathesis reaction of an aromatic α...
Scheme 90: Preparation of a macrocyclic ring system containing 1,4-bis(propadienyl)benzene units.
Scheme 91: Preparation of copolymers from 1,4-bis(propadienyl)benzene (376).
Scheme 92: A boration/copolymerization sequence of an aromatic bisallene and an aromatic bisacetylene.
Scheme 93: Formation of a layered aromatic bisallene.
Figure 4: The first members of the semicyclic bisallene series.
Scheme 94: Preparation of the first bis(vinylidene)cyclobutane derivative.
Scheme 95: Dimerization of strain-activated cumulenes to bis(vinylidene)cyclobutanes.
Scheme 96: Photodimerization of two fully substituted butatrienes in the solid state.
Scheme 97: Preparation of the two parent bis(vinylidene)cyclobutanes.
Scheme 98: The preparation of 1,3-bis(vinylidene)cyclopentane and its thermal isomerization.
Scheme 99: The preparation of the isomeric bis(vinylidene)cyclohexanes.
Scheme 100: Bi- and tricyclic conjugated bisallenes.
Scheme 101: A selection of polycyclic bisallenes.
Scheme 102: The first endocyclic bisallenes.
Figure 5: The stereochemistry of 1,2,6,7-cyclodecatetraene.
Scheme 103: The preparation of several endocyclic bisallenes.
Scheme 104: Synthesis of diastereomeric derivatives of 1,2,6,7-cyclodecatetraene.
Scheme 105: Preparation of a derivative of 1,2,8,9-cyclotetradecatetraene.
Scheme 106: The preparation of keto derivatives of cyclic bisallenes.
Scheme 107: The preparation of cyclic biscumulenic ring systems.
Scheme 108: Cyclic bisallenes in natural- and non-natural-product chemistry.
Scheme 109: The preparation of iron carbonyl complexes from cyclic bisallenes.
Figure 6: A selection of unknown exocyclic bisallenes that should have interesting chemical properties.
Scheme 110: The thermal isomerization of 1,2-diethynylcyclopropanes and -cyclobutanes.
Scheme 111: Intermediate generation of a cyclooctapentaene.
Scheme 112: Attempted preparation of a cyclodecahexaene.
Scheme 113: The thermal isomerization of 1,5,9-cyclododecatriyne (511) into [6]radialene (514).
Scheme 114: An isomerization involving a diketone derived from a conjugated bisallene.
Scheme 115: Typical reaction modes of heteroorganic bisallenes.
Scheme 116: Generation and thermal behavior of acyclic hetero-organic bisallenes.
Scheme 117: Generation of bis(propadienyl)thioether.
Scheme 118: The preparation of a bisallenic sulfone and its thermal isomerization.
Scheme 119: Bromination of the bisallenic sulfone 535.
Scheme 120: Metalation/hydrolysis of the bisallenic sulfone 535.
Scheme 121: Aromatic compounds from hetero bisallenes.
Scheme 122: Isomerization/cyclization of bispropargylic ethers.
Scheme 123: The preparation of novel aromatic systems by base-catalyzed isomerization of bispropargyl ethers.
Scheme 124: The isomerization of bisacetylenic thioethers to bicyclic thiophenes.
Scheme 125: Aromatization of macrocyclic bispropargylic sulfides.
Scheme 126: Preparation of ansa-compounds from macrocyclic bispropargyl thioethers.
Scheme 127: Alternate route for cyclization of a heterorganic bisallene.
Scheme 128: Multiple isomerization/cyclization of “double” bispropargylic thioethers.
Scheme 129: Preparation of a bisallenyl disulfide and its subsequent bicyclization.
Scheme 130: Thermal cyclization of a bisallenyl thiosulfonate.
Scheme 131: Some reactions of heteroorganic bisallenes with two sulfur atoms.
Scheme 132: Further methods for the preparation of heteroorganic bisallenes.
Scheme 133: Cyclization reactions of heteroorganic bisallenes.
Scheme 134: Thermal cycloadditions of bisallenic tertiary amines.
Scheme 135: Cyclization of a bisallenic tertiary amine in the presence of a transition-metal catalyst.
Scheme 136: A Pauson–Khand reaction of a bisallenic ether.
Scheme 137: Formation of a 2:1adduct from two allenic substrates.
Scheme 138: A ring-forming silastannylation of a bisallenic tertiary amine.
Scheme 139: A three-component cyclization involving a heterorganic bisallene.
Scheme 140: Atom-economic construction of a complex organic framework from a heterorganic α,ω-bisallene.
Beilstein J. Org. Chem. 2012, 8, 1528–1535, doi:10.3762/bjoc.8.173
Graphical Abstract
Scheme 1: Mechanism of free radical ring-opening polymerization of 2-VCPs (In: initiator) [29-31].
Scheme 2: Synthesis of diethyl 2-vinyl-1,1-cyclopropanedicarboxylate [33].
Scheme 3: Two-step synthesis of the macromonomer 5 (In: Initiator, TEA: triethylamine).
Figure 1: MALDI-TOF MS of amino-terminated poly(NiPAAm) 3.
Figure 2: Optical transmittance of aqueous solutions (c = 20 mg/mL) of 3, 6 und 8 during heating.
Figure 3: 2D ROESY NMR spectrum of a 5/Me2-β-CD deuterated water solution.
Figure 4: Temperature-dependent transparency measurements of aqueous solution of the supramolecular complex 7...
Scheme 4: Homo- and copolymerization of macromonomer 5.
Beilstein J. Org. Chem. 2012, 8, 1360–1365, doi:10.3762/bjoc.8.157
Graphical Abstract
Figure 1: Cinchona alkaloid-derived catalysts screened for condition optimization (Table 1).
Scheme 1: A one-pot synthesis of enantioenriched 3,3-diaryloxindoles.
Beilstein J. Org. Chem. 2012, 8, 749–752, doi:10.3762/bjoc.8.85
Graphical Abstract
Figure 1: Structures of pseudopyronines A (1) and B (2) and natural oxazoles (3–8) as well as synthetic oxazo...
Figure 2: MS data from strain PB22.5, which was cultivated in [U-13C] and [U-15N] medium background and LB me...
Figure 3: All incorporated biosynthetic precursors of the oxazoles are shown in color. The nitrogen shown in ...
Beilstein J. Org. Chem. 2012, 8, 461–471, doi:10.3762/bjoc.8.53
Graphical Abstract
Scheme 1: Preparation of ArSF4Cl 2.
Scheme 2: Preparation of Ar(SF4Cl)n from Ar(SH)n (n = 2, 3).
Scheme 3: Reaction mechanism for the formation of ArSF4Cl.
Scheme 4: Reaction mechanism for the formation of trans and cis-ArSF4Cl.
Scheme 5: Preparation of ArSF5 with ZnF2.
Scheme 6: Preparation of PhSF5 with anhydrous HF.
Scheme 7: Preparation of 3a with HF–pyridine.
Scheme 8: Preparation of polyfluorinated ArSF5.
Scheme 9: Preparation of aryl bis- and tris(sulfur pentafluorides), Ar(SF5)n (n = 2,3).
Beilstein J. Org. Chem. 2012, 8, 344–348, doi:10.3762/bjoc.8.38
Graphical Abstract
Scheme 1: Synthesis of 1-carbamoyl-2-oxopropyl acetates.
Scheme 2: Synthesis of 2,2-dihalo-N-phenylacetamides.
Scheme 3: Synthesis of dichloroacetamides. Reagents and conditions: 1 (1.0 mmol), dioxane (2 mL), DIB (1.3 eq...
Scheme 4: Synthesis of dibromoacetamides. Reagents and conditions: 1 (1.0 mmol), dioxane (2 mL), DIB (1.3 equ...
Scheme 5: Probe the mechanism.
Scheme 6: Tentative mechanism for the synthesis of 2,2-dihalo-N-phenylacetamides.
Beilstein J. Org. Chem. 2012, 8, 253–258, doi:10.3762/bjoc.8.26
Graphical Abstract
Scheme 1: Cross-coupling reactions of bipyridines 2.
Scheme 2: Ligand effect in the double N-arylation of 2a with 6a.
Figure 1: Unsuccessful substrates in the double N-arylation of 2a.
Scheme 3: Functionalization of diazacarbazole 2a.
Scheme 4: Functionalized diazacarbazoles 12a–c from bipyridine 2b.
Figure 2: (a) ORTEP views showing the π–π (dashed lines) and selected C–H···π (dotted-dashed line) interactio...
Beilstein J. Org. Chem. 2012, 8, 129–154, doi:10.3762/bjoc.8.15
Graphical Abstract
Scheme 1: Examples for bent mesogens containing salicylideneimine moieties.
Scheme 2: Synthetic pathway to prepare compounds OH 1.
Figure 1: Polarising optical microscopy images. a) Compound OH 1a: Grainy texture with smectic Schlieren area...
Figure 2: X-ray diffraction pattern of a powderlike sample of OH 1b at 131 °C (inset: Small angle region; low...
Figure 3: Electro-optical behaviour of compound OH 1a: a) current response curve (U = 182 Vpp, f = 30 Hz, T =...
Figure 4: Switching behaviour of compound H 1a, which depends on how quickly the electric field is switched o...
Scheme 3: Reaction pathways to prepare the monosalicylideneaniline compounds OH 2a–j.
Figure 5: Compound OH 2a: Texture of the SmCP phase at 126 °C.
Figure 6: a) 2D X-ray pattern of a surface-aligned sample of compound OH 2a at 128 °C (lower part of the patt...
Figure 7: Electro-optical switching behaviour of compound OH 2a: a) current response (U = 230 Vpp, f = 25 Hz, ...
Scheme 4: Synthetic steps followed to prepare the compounds OH 3 and OH 4.
Figure 8: Optical photomicrographs of compound OH 3a: a) On cooling of the isotropic liquid; c) U = 0 V; b) U...
Figure 9: Electro-optical behaviour of compound OH 3a: a) Current response curve (U = 308 Vpp, f = 35 Hz, T =...
Figure 10: Growth of a fan-shaped texture from lancetlike filaments upon cooling of the isotropic liquid of co...
Figure 11: a) 2D X-ray pattern of a surface-aligned sample of compound OH 3b at 160 °C (lower part of the patt...
Figure 12: Compound OH 3b: Texture of the SmCPA phase in dependence on the polarity of the applied D.C. field.
Figure 13: Compound OH 4b, exhibiting a fan-shaped texture together with a Schlieren texture upon cooling of t...
Figure 14: 2D X-ray diffraction pattern of a partially surface-aligned sample of OH 4b at 115 °C (inset: Small...
Figure 15: Switching behaviour of compound OH 4b at 120 °C: a) Current response curve (U = 116 Vpp, f = 40 Hz, ...
Figure 16: Compound OH 4d: a) Microphotograph of a growing fringe pattern of a SmCP phase upon cooling of the ...
Figure 17: Electro-optical behaviour observed on the fan-shaped texture of compound OH 4d; UD.C. = 47 V; T = 1...
Figure 18: a) 2D X-ray diffraction pattern for a surface-aligned sample of OH 4d at 122 °C on cooling; b) χ-sc...
Scheme 5: Reaction steps employed for the preparation of the compounds OH 5 and OH 6.
Figure 19: Compound OH 5d: Optical photomicrographs of chiral domains at 122 °C; polariser and analyser are un...
Figure 20: Compound OH 5b: a), b) Chiral domains at 175 °C, 0 V, polarisers uncrossed by about ±8° from the 90...
Figure 21: X-ray diffraction patterns of compounds OH 5: a) Pattern of a powderlike sample of compound OH 5g a...
Figure 22: Photomicrographs of compound OH 5f: a) Appearance of spiral filaments on slow cooling of the isotro...
Figure 23: Current response of compound OH 6b exhibiting two repolarisation peaks proving an antiferroelectric...
Figure 24: On cooling the isotropic liquid phase of compound OH 6c; a Schlieren texture together with fringe p...
Figure 25: Electro-optical behaviour of compound OH 6c: a) Current response (UA.C. = 17 V/µm, f = 39 Hz, T = 1...
Beilstein J. Org. Chem. 2011, 7, 1622–1635, doi:10.3762/bjoc.7.191
Graphical Abstract
Figure 1: Cyanobacteria proliferate in diverse habitats. A) Bloom-forming freshwater cyanobacteria of the gen...
Figure 2: Schematic representation of enzymatic domains in A) nonribosomal peptide synthetases (NRPS); B) pol...
Figure 3: Structures of NRPS and PKS products in freshwater cyanobacteria.
Figure 4: A) Synthesis of the Adda ((2S,3S,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyl-4,6-decadienoic...
Figure 5: Structures of NRPS and PKS products in marine cyanobacteria.
Figure 6: A) Formation of the trichloroleucyl starter unit of barbamide (7) synthesis through the non-heme ir...
Figure 7: Structures of NRPS and PKS products in terrestrial cyanobacteria.
Figure 8: Synthesis of the (2S,4S)-4-methylproline moiety of nostopeptolides A (13).
Figure 9: Structures of cyanobacterial peptides that are synthesized ribosomally and post-translationally mod...
Figure 10: Formation of ester linkages and ω-amide linkage in microviridins 17 by the ATP grasp ligases MvdD a...
Figure 11: Structures of cyanobacterial sunscreen compounds.
Beilstein J. Org. Chem. 2011, 7, 1130–1134, doi:10.3762/bjoc.7.130
Graphical Abstract
Scheme 1: Preparation of salts and/or complexes 4, 5 and 6.
Figure 1: UV–vis spectra of complex 4 in basic solution (pH 10, t = 0 (blue line), t = 24 h (red line), t = 4...
Figure 2: UV–vis spectra of complex 5 in solution before heating (solid line) and after 30 min of heating at ...
Figure 3: UV–vis spectra of complex 6 in solution (pH 6) before heating (solid line) and after 30 min heating...
Figure 4: UV–vis spectra of complex 6 in basic solution (pH 10) before heating (solid line), after 24 h witho...
Beilstein J. Org. Chem. 2011, 7, 1075–1094, doi:10.3762/bjoc.7.124
Graphical Abstract
Scheme 1: AuCl3-catalyzed benzannulations reported by Yamamoto.
Scheme 2: Synthesis of 9-oxabicyclo[3.3.1]nona-4,7-dienes from 1-oxo-4-oxy-5-ynes [40].
Scheme 3: Stereocontrolled oxacyclization/(4 + 2)-cycloaddition cascade of ketone–allene substrates [43].
Scheme 4: Gold-catalyzed synthesis of polycyclic, fully substituted furans from 1-(1-alkynyl)cyclopropyl keto...
Scheme 5: Gold-catalyzed 1,3-dipolar cycloaddition of 2-(1-alkynyl)-2-alken-1-ones with nitrones [47].
Scheme 6: Enantioselective 1,3-dipolar cycloaddition of 2-(1-alkynyl)-2-alken-1-ones with nitrones [48].
Scheme 7: Gold-catalyzed 1,3-dipolar cycloaddition of 2-(1-alkynyl)-2-alken-1-ones with α,β-unsaturated imine...
Scheme 8: Gold-catalyzed (4 + 3) cycloadditions of 1-(1-alkynyl)oxiranyl ketones [50].
Scheme 9: (3 + 2) Cycloaddition of gold-containing azomethine ylides [52].
Scheme 10: Gold-catalyzed generation and reaction of azomethine ylides [53].
Scheme 11: Gold-catalyzed intramolecular (4 + 2) cycloadditions of unactivated alkynes and dienes [55].
Scheme 12: Gold-catalyzed preparation of bicyclo[4.3.0]nonane derivatives from dienol silyl ethers [59].
Scheme 13: Gold(I)-catalyzed intramolecular (4 + 2) cycloadditions of arylalkynes or 1,3-enynes with alkenes [60].
Scheme 14: Gold(I)-catalyzed intermolecular (2 + 2) cycloaddition of alkynes with alkenes [62].
Scheme 15: Metal-catalyzed cycloaddition of alkynes tethered to cycloheptatriene [65].
Scheme 16: Gold-catalyzed cycloaddition of functionalized ketoenynes: Synthesis of (+)-orientalol F [68].
Scheme 17: Gold-catalyzed intermolecular cyclopropanation of enynes with alkenes [70].
Scheme 18: Gold-catalyzed intermolecular hetero-dehydro Diels–Alder cycloaddition [72].
Figure 1: Gold-catalyzed 1,2- or 1,3-acyloxy migrations of propargyl esters.
Scheme 19: Gold(I)-catalyzed stereoselective olefin cyclopropanation [74].
Scheme 20: Reaction of propargylic benzoates with α,β-unsaturated imines to give azepine cycloadducts [77].
Scheme 21: Gold-catalyzed (3 + 3) annulation of azomethine imines with propargyl esters [81].
Scheme 22: Gold(I)-catalyzed isomerization of 5-en-2-yn-1-yl acetates [83].
Scheme 23: (3 + 2) and (2 + 2) cycloadditions of indole-3-acetates 41 [85,86].
Scheme 24: Gold(I)-catalyzed (2 + 2) cycloaddition of allenenes [87].
Scheme 25: Formal (3 + 2) cycloaddition of allenyl MOM ethers and alkenes [90].
Scheme 26: (4 + 3) Cycloadditions of allenedienes [97,98].
Scheme 27: Gold-catalyzed transannular (4 + 3) cycloaddition reactions [101].
Scheme 28: Gold(I)-catalyzed (4 + 2) cycloadditions of allenedienes [102].
Scheme 29: Enantioselective gold(I)-catalyzed (4 + 2) cycloadditions of allenedienes [88,102,104].
Scheme 30: (3 + 2) versus (2 + 2) Cycloadditions of allenenes [87,99].
Figure 2: NHC ligands with different π-acceptor properties [106].
Scheme 31: (3 + 2) versus (2 + 2) Cycloadditions of allenenes [106].
Scheme 32: Gold(I)-catalyzed intermolecular (4 + 2) cycloaddition of allenamides and acyclic dienes [109].
Beilstein J. Org. Chem. 2011, 7, 980–987, doi:10.3762/bjoc.7.110
Graphical Abstract
Scheme 1: Povarov oxidation access to substituted quinolines.
Scheme 2: Tetrahydroquinoline oxidation.
Scheme 3: Synthesis of the Povarov adducts and their oxidation products.
Figure 1: Optimization of the reaction conditions for the preparation of quinoline 18.
Scheme 4: Oxidation of lactam-fused tetrahydroquinolines 20,20'.
Beilstein J. Org. Chem. 2011, 7, 442–495, doi:10.3762/bjoc.7.57
Graphical Abstract
Figure 1: Structures of atorvastatin and other commercial statins.
Figure 2: Structure of compactin.
Scheme 1: Synthesis of pentasubstituted pyrroles.
Scheme 2: [3 + 2] Cycloaddition to prepare 5-isopropylpyrroles.
Scheme 3: Regiospecific [3 + 2] cycloaddition to prepare the pyrrole scaffold.
Scheme 4: Formation of the pyrrole core of atorvastatin via [3 + 2] cycloaddition.
Scheme 5: Formation of pyrrole 33 via the Paal–Knorr reaction.
Scheme 6: Convergent synthesis towards atorvastatin.
Figure 3: Binding pocket of sunitinib in the TRK KIT.
Scheme 7: Synthesis of sunitinib.
Scheme 8: Alternative synthesis of sunitinib.
Scheme 9: Key steps in the syntheses of sumatriptan and zolmitriptan.
Scheme 10: Introduction of the N,N-dimethylaminoethyl side chain.
Scheme 11: Japp–Klingemann reaction in the synthesis of sumatriptan.
Scheme 12: Synthesis of the intermediate sulfonyl chlorides 62 and 63.
Scheme 13: Alternative introduction of the sulfonamide.
Scheme 14: Negishi-type coupling to benzylic sulfonamides.
Scheme 15: Heck reaction used to introduce the sulfonamide side chain of naratriptan.
Scheme 16: Synthesis of the oxazolinone appendage of zolmitriptan.
Scheme 17: Grandberg indole synthesis used in the preparation of rizatriptan.
Scheme 18: Improved synthesis of rizatriptan.
Scheme 19: Larock-type synthesis of rizatriptan.
Scheme 20: Synthesis of eletriptan.
Scheme 21: Heck coupling for the indole system in eletriptan.
Scheme 22: Attempted Fischer indole synthesis of elatriptan.
Scheme 23: Successful Fischer indole synthesis for eletriptan.
Scheme 24: Mechanistic rationale for the Bischler–Möhlau reaction.
Scheme 25: Bischler-type indole synthesis used in the fluvastatin sodium synthesis.
Scheme 26: Palladium-mediated synthesis of ondansetron.
Scheme 27: Fischer indole synthesis of ondansetron.
Scheme 28: Optimised Pictet–Spengler reaction towards tadalafil.
Figure 4: Structures of carvedilol 136 and propranolol 137.
Scheme 29: Synthesis of the carbazole core of carvedilol.
Scheme 30: Alternative syntheses of 4-hydroxy-9H-carbazole.
Scheme 31: Convergent synthesis of etodolac.
Scheme 32: Alternative synthesis of etodolac.
Figure 5: Structures of imidazole-containing drugs.
Scheme 33: Synthesis of functionalised imidazoles towards losartan.
Scheme 34: Direct synthesis of the chlorinated imidazole in losartan.
Scheme 35: Synthesis of trisubstituted imidazoles.
Scheme 36: Preparation of the imidazole ring in olmesartan.
Scheme 37: Synthesis of ondansetron.
Scheme 38: Alternative route to ondansetron and its analogues.
Scheme 39: Proton pump inhibitors and synthesis of esomeprazole.
Scheme 40: Synthesis of benzimidazole core pantoprazole.
Figure 6: Structure of rabeprazole 194.
Scheme 41: Synthesis of candesartan.
Scheme 42: Alternative access to the candesartan key intermediate 216.
Scheme 43: .Medicinal chemistry route to telmisartan.
Scheme 44: Improved synthesis of telmisartan.
Scheme 45: Synthesis of zolpidem.
Scheme 46: Copper-catalysed 3-component coupling towards zolpidem.
Figure 7: Structure of celecoxib.
Scheme 47: Preparation of celecoxib.
Scheme 48: Alternative synthesis of celecoxib.
Scheme 49: Regioselective access to celecoxib.
Scheme 50: Synthesis of pazopanib.
Scheme 51: Syntheses of anastrozole, rizatriptan and letrozole.
Scheme 52: Regioselective synthesis of anastrozole.
Scheme 53: Triazine-mediated triazole formation towards anastrozole.
Scheme 54: Alternative routes to 1,2,4-triazoles.
Scheme 55: Initial synthetic route to sitagliptin.
Figure 8: Binding of sitagliptin within DPP-IV.
Scheme 56: The process route to sitagliptin key intermediate 280.
Scheme 57: Synthesis of maraviroc.
Scheme 58: Synthesis of alprazolam.
Scheme 59: The use of N-nitrosoamidine derivatives in the preparation of fused benzodiazepines.
Figure 9: Structures of itraconazole, ravuconazole and voriconazole.
Scheme 60: Synthesis of itraconazole.
Scheme 61: Synthesis of rufinamide.
Scheme 62: Representative tetrazole formation in valsartan.
Figure 10: Structure of tetrazole containing olmesartan, candesartan and irbesartan.
Scheme 63: Early stage introduction of the tetrazole in losartan.
Scheme 64: Synthesis of cilostazol.
Figure 11: Structure of cefdinir.
Scheme 65: Semi-synthesis of cefdinir.
Scheme 66: Thiazole syntheses towards ritonavir.
Scheme 67: Synthesis towards pramipexole.
Scheme 68: Alternative route to pramipexole.
Scheme 69: Synthesis of famotidine.
Scheme 70: Efficient synthesis of the hyperuricemic febuxostat.
Scheme 71: Synthesis of ziprasidone.
Figure 12: Structure of mometasone.
Scheme 72: Industrial access to 2-furoic acid present in mometasone.
Scheme 73: Synthesis of ranitidine from furfuryl alcohol.
Scheme 74: Synthesis of nitrofurantoin.
Scheme 75: Synthesis of benzofuran.
Scheme 76: Synthesis of amiodarone.
Scheme 77: Synthesis of raloxifene.
Scheme 78: Alternative access to the benzo[b]thiophene core of raloxifene.
Scheme 79: Gewald reaction in the synthesis of olanzapine.
Scheme 80: Alternative synthesis of olanzapine.
Figure 13: Access to simple thiophene-containing drugs.
Scheme 81: Synthesis of clopidogrel.
Scheme 82: Pictet–Spengler reaction in the preparation of tetrahydrothieno[3,2-c]pyridine (422).
Scheme 83: Alternative synthesis of key intermediate 422.
Figure 14: Co-crystal structures of timolol (left) and carazolol (right) in the β-adrenergic receptor.
Scheme 84: Synthesis of timolol.
Scheme 85: Synthesis of tizanidine 440.
Scheme 86: Synthesis of leflunomide.
Scheme 87: Synthesis of sulfamethoxazole.
Scheme 88: Synthesis of risperidone.
Figure 15: Relative abundance of selected transformations.
Figure 16: The abundance of heterocycles within top 200 drugs (5-membered rings).
Beilstein J. Org. Chem. 2011, 7, 179–197, doi:10.3762/bjoc.7.25
Graphical Abstract
Figure 1: Pharmacologically active 5-aminopyrazoles.
Scheme 1: General equation for the condensation of β-ketonitriles with hydrazines.
Scheme 2: Reaction of hydrazinoheterocycles with α-phenyl-β-cyanoketones (4).
Scheme 3: Condensation of cyanoacetaldehyde (7) with hydrazines.
Scheme 4: Synthesis of 5-aminopyrazoles and their sulfonamide derivatives.
Scheme 5: Synthesis of 5-aminopyrazoles, containing a cyclohexylmethyl- or phenylmethyl- sulfonamido group at...
Scheme 6: Regioselective synthesis of 3-amino-2-alkyl (or aryl) thieno[3,4-c]pyrazoles 19.
Scheme 7: Solid supported synthesis of 5-aminopyrazoles.
Scheme 8: Synthesis of 5-aminopyrazoles from resin supported enamine nitrile 25 as the starting material.
Scheme 9: Two-step “catch and release” solid-phase synthesis of 3,4,5-trisubstituted pyrazoles.
Scheme 10: Synthesis of pyrazolo[5,1-d][1,2,3,5]tetrazine-4(3H)-ones.
Scheme 11: Synthesis of the 5,5-ring system, imidazo[1,2-b]pyrazol-2-ones.
Scheme 12: Synthesis of 5-amino-3-(pyrrol-2-yl)pyrazole-4-carbonitrile.
Scheme 13: Synthesis of N-(1,3-diaryl-1H-pyrazol-5-yl)benzamide.
Scheme 14: Synthesis of 3,7-bis(arylazo)-6-methyl-2-phenyl-1H-imidazo[1,2-b]pyrazoles.
Scheme 15: Synthesis of 3,5-diaminopyrazole.
Scheme 16: Synthesis of 5-amino-4-cyanopyrazole and 5-amino-3-hydrazinopyrazole.
Scheme 17: Synthesis of 3,5-diaminopyrazoles with substituted malononitriles.
Scheme 18: Synthesis of 3,5-diamino-4-oximinopyrazole.
Scheme 19: Synthesis of 4-arylazo-3,5-diaminopyrazoles.
Scheme 20: Synthesis of 3- or 5-amino-4-cyanopyrazoles.
Scheme 21: Synthesis of triazenopyrazoles.
Scheme 22: Synthesis of 5(3)-aminopyrazoles.
Scheme 23: Synthesis of 3-substituted 5-amino-4-cyanopyrazoles.
Scheme 24: Synthesis of 2-{[(1-acetyl-4-cyano-1H-pyrazol-5-yl)amino]methylene}malononitrile.
Scheme 25: Synthesis of 5-aminopyrazole carbodithioates and 5-amino-3-arylamino-1-phenylpyrazole-4-carboxamide...
Scheme 26: Synthesis of 5-amino-4-cyanopyrazoles.
Scheme 27: Synthesis of thiazolylpyrazoles.
Scheme 28: Synthesis of 5-amino-1-heteroaryl-3-methyl/aryl-4-cyanopyrazoles.
Scheme 29: Synthesis of 5-amino-3-methylpyrazole-4-carboxamide.
Scheme 30: Synthesis of 4-acylamino-3(5)-amino-5(3)-arylsulfanylpyrazoles.
Scheme 31: Synthesis of 5-amino-1-aryl-4-diethoxyphosphoryl-3-halomethylpyrazoles.
Scheme 32: Synthesis of substituted 5-amino-3-trifluoromethylpyrazoles 114 and 118.
Scheme 33: Solid-support synthesis of 5-N-alkylamino and 5-N-arylaminopyrazoles.
Scheme 34: Synthesis of 5-amino-1-cyanoacetyl-3-phenyl-1H-pyrazole.
Scheme 35: Synthesis of 3-substituted 5-amino-1-aryl-4-(benzothiazol-2-yl)pyrazoles.
Scheme 36: Synthesis of 5-amino-4-carbethoxy-3-methyl-1-(4-sulfamoylphenyl)pyrazole.
Scheme 37: Synthesis of inhibitors of hsp27-phosphorylation and TNFa-release.
Scheme 38: Synthesis of the diglycylpyrazole 142.
Scheme 39: Synthesis of 5-amino-1-aryl-4-benzoylpyrazole derivatives.
Scheme 40: Synthesis of 4-benzoyl-3,5-diamino-1-(2-cyanoethyl)pyrazole.
Scheme 41: Synthesis of the 5-aminopyrazole derivative 150.
Scheme 42: Synthesis of 3,5-diaminopyrazoles 153.
Scheme 43: Synthesis of 5-aminopyrazoles derivatives 155 via lithiated intermediates.
Scheme 44: Synthesis of 5-amino-4-(1,2,4-oxadiazol-5-yl)-pyrazoles 157.
Scheme 45: Synthesis of a 5-aminopyrazole with anticonvulsant activity.
Scheme 46: Synthesis of tetrasubstituted 5-aminopyrazole derivatives.
Scheme 47: Synthesis of substituted 5-aminopyrazoles from hydrazonoyl halides.
Scheme 48: Synthesis of 3-amino-5-phenylpyrazoles from isothiazoles.
Scheme 49: Synthesis of 5-aminopyrazoles via ring transformation.
Beilstein J. Org. Chem. 2011, 7, 113–118, doi:10.3762/bjoc.7.16
Graphical Abstract
Scheme 1: The Paternò–Büchi reaction of DMT/DMU with benzophenones to generate two regioisomeric photoproduct...
Figure 1: The yield and the ratio of 2/3 at different reaction times in the Paternò–Büchi reaction of DMT wit...
Figure 2: Eyring plots for the photoreaction of DMT with compounds 1b–e.
Scheme 2: The formational processes of two regioisomers in the Paternò–Büchi reaction of DMT/DMU with benzoph...
Beilstein J. Org. Chem. 2011, 7, 104–110, doi:10.3762/bjoc.7.14
Graphical Abstract
Scheme 1: Synthesis of complex 1a.
Scheme 2: Synthesis of complexes 2 and 3.
Scheme 3: Synthesis of complexes 1b–i.
Figure 1: Naphthyl-group region of 1H,1H-COSY NMR for 1g in CD2Cl2 at −80 °C.
Figure 2: 1H NMR (top) and NOE difference spectrum (bottom) of 1g in CD2Cl2 at −80 °C, saturating the methyli...
Scheme 4: Conformational isomerism in complex 1g.
Figure 3: Olefin and alkylidene-proton region of the 1H NMR (top) and NOE difference spectrum (bottom) of 1e ...
Scheme 5: Conformational isomerism in complex 1e.
Figure 4: Olefin and alkyl group region of the 1H NMR (top) and NOE difference spectrum (bottom) of 1e in CD2...
Beilstein J. Org. Chem. 2010, 6, 1167–1173, doi:10.3762/bjoc.6.133
Graphical Abstract
Scheme 1: Reaction of homobimetallic ruthenium–indenylidene complex 1 with ethylene.
Scheme 2: Schematic illustration of tandem assisted catalysis with complexes 1 and 2.
Scheme 3: Tandem RCM/ATRC of 2,2,2-trichloro-N-(octa-1,7-dien-3-yl)acetamide (4) catalyzed by complex 1.
Scheme 4: Ruthenium catalyzed transformation of substrate 16.
Beilstein J. Org. Chem. 2010, 6, 1149–1158, doi:10.3762/bjoc.6.131
Graphical Abstract
Figure 1: Olefin isomerization during ADMET polymerization.
Figure 2: Ru–indenylidene metathesis catalysts C1 and C2, “boomerang” complexes C3, and Hoveyda–Grubbs 2nd ge...
Figure 3: Representative scheme for the in situ generated Ru–indenylidene [38].
Figure 4: Synthesis of the studied α,ω-diene, its ADMET polymerization, and the strategy to evaluate isomeriz...
Figure 5: GPC traces of the polymerizations performed at 60, 80, 100 and 120 ºC in presence of a) 0.5 mol % C1...
Figure 6: GC-MS study of the acid-catalyzed degradation products of polymers P19, P20, P21, and P22.
Figure 7: GPC traces of polymerizations performed with C1 at 80, 100, and 120 ºC. Samples taken at 5 min (―–)...
Figure 8: DSC traces of ADMET polymers P11 and P12 (Table 1, entries 11 and 12, respectively).
Beilstein J. Org. Chem. 2010, 6, 1106–1119, doi:10.3762/bjoc.6.127
Graphical Abstract
Scheme 1: Light activated metathesis of trans-2-pentene.
Scheme 2: Light induced generation of metathesis active species 2.
Figure 1: Well-defined tungsten photoactive catalysts.
Figure 2: The first ruthenium based complexes for PROMP.
Figure 3: Cyclic strained alkenes for PROMP.
Scheme 3: Proposed mechanism for photoactivation of sandwich complexes.
Figure 4: Ruthenium and osmium complexes with p-cymene and phosphane ligands for PROMP.
Figure 5: Commercially available photoactive ruthenium precatalyst.
Figure 6: Some of the rings produced by photo-RCM.
Scheme 4: Photopromoted ene-yne RCM by cationic allenylidene ruthenium complex 14.
Figure 7: Dihydrofurans synthesised by photopromoted ene-yne RCM.
Figure 8: Ruthenium complexes with p-cymene and NHC ligands.
Scheme 5: Ruthenium NHC complexes for PROMP containing p-cymene and trifluroacetate (17, 19) or phenylisonitr...
Figure 9: Photoactivated cationic ROMP precatalysts.
Figure 10: Different monomers for PROMP.
Scheme 6: Proposed mechanism for photoinitiated polymerisation by 22 and 23.
Figure 11: Light-induced cationic catalysts for ROMP.
Figure 12: Sulfur chelated ruthenium benzylidene pre-catalysts for olefin metathesis.
Scheme 7: Proposed mechanism for the photoactivation of sulfur-chelated ruthenium benzylidene.
Figure 13: Photoacid generators for photoinduced metathesis.
Scheme 8: Synthesis of precatalysts 36 and 37.
Scheme 9: Trapping of proposed intermediate 41.
Figure 14: Encapsulated 39, isolated from the monomer.
Beilstein J. Org. Chem. 2010, 6, 1091–1098, doi:10.3762/bjoc.6.125
Graphical Abstract
Figure 1: General layout for modifications of ruthenium-based olefin metathesis catalysts (red: anionic ligan...
Scheme 1: Synthesis of 1, 2 and 3.
Figure 2: Details of the 1H NMR spectra acquired during the synthesis of 2 and the FD-MS spectrum of 2 isolat...
Figure 3: ORTEP drawing of 3. Thermal ellipsoids are drawn at 50% probability level. Hydrogen atoms are omitt...
Figure 4: Polymerisation of 4 as a function of time, initiated by 1, 2 or 3, monitored by 1H NMR spectroscopy...
Figure 5: Polymerisations of 6 as a function of time, initiated by 1–3, monitored by 1H NMR spectroscopy (sol...
Figure 6: The RCM reaction of 7 as a function of time, catalysed by 1, 2 or 3, monitored by 1H NMR spectrosco...
Beilstein J. Org. Chem. 2010, 6, No. 48, doi:10.3762/bjoc.6.48
Graphical Abstract
Scheme 1: Diels–Alder reaction of diene 2 with 4 and 6. aThe other isomers of 7a and 7b were isolated in 8% a...
Scheme 2: Synthetic concept toward multi-substituted gem-difluoroisoquinolinones.
Figure 1: Comparison of coupling constant of vinyl protons.
Scheme 3: Diels–Alder reaction with 9 and 6. aCombined yield of two isomers.
Beilstein J. Org. Chem. 2010, 6, No. 32, doi:10.3762/bjoc.6.32
Graphical Abstract
Figure 1: Biologically important amines and quaternary ammonium salts: histamine (1), dopamine (2) and acetyl...
Figure 2: Crown ether 18-crown-6.
Figure 3: Conformations of 18-crown-6 (4) in solvents of different polarity.
Figure 4: Binding topologies of the ammonium ion depending on the crown ring size.
Figure 5: A “pseudorotaxane” structure consisting of 24-crown-8 and a secondary ammonium ion (5); R = Ph.
Figure 6: Typical examples of azacrown ethers, cryptands and related aza macrocycles.
Figure 7: Binding of ammonium to azacrown ethers and cryptands [111-113].
Figure 8: A 19-crown-6-ether with decalino blocking groups (11) and a thiazole-dibenzo-18-crown-6-ether (12).
Figure 9: 1,3-Bis(6-oxopyridazin-1-yl)propane derivatives 13 and 14 by Campayo et al.
Figure 10: Fluorescent azacrown-PET-sensors based on coumarin.
Figure 11: Two different pyridino-cryptands (17 and 18) compared to a pyridino-crown (19); chiral ammonium ion...
Figure 12: Pyridino-18-crown-6 ligand (21), a similar acridino-18-crown-6 ligand (22) and a structurally relat...
Figure 13: Ciral pyridine-azacrown ether receptors 24.
Figure 14: Chiral 15-crown-5 receptors 26 and an analogue 18-crown-6 ligand 27 derived from amino alcohols.
Figure 15: C2-symmetric chiral 18-crown-6 amino alcohol derivatives 28 and related macrocycles.
Figure 16: Macrocycles with diamide-diester groups (30).
Figure 17: C2-symmetric chiral aza-18-crown-6 ethers (31) with phenethylamine residues.
Figure 18: Chiral C-pivot p-methoxy-phenoxy-lariat ethers.
Figure 19: Chiral lariat crown ether 34.
Figure 20: Sucrose-based chiral crown ether receptors 36.
Figure 21: Permethylated fructooligosaccharide 37 showing induced-fit chiral recognition.
Figure 22: Biphenanthryl-18-crown-6 derivative 38.
Figure 23: Chiral lariat crown ethers derived from binol by Fuji et al.
Figure 24: Chiral phenolic crown ether 41 with “aryl chiral barriers” and guest amines.
Figure 25: Chiral bis-crown receptor 43 with a meso-ternaphthalene backbone.
Figure 26: Chromogenic pH-dependent bis-crown chemosensor 44 for diamines.
Figure 27: Triamine guests for binding to receptor 44.
Figure 28: Chiral bis-crown phenolphthalein chemosensors 46.
Figure 29: Crown ether amino acid 47.
Figure 30: Luminescent receptor 48 for bis-alkylammonium guests.
Figure 31: Luminescent CEAA (49a), a bis-CEAA receptor for amino acids (49b) and the structure of lysine bindi...
Figure 32: Luminescent CEAA tripeptide for binding small peptides.
Figure 33: Bis crown ether 51a self assembles co-operatively with C60-ammonium ion 51b.
Figure 34: Triptycene-based macrotricyclic dibenzo-[24]-crown-8 ether host 52 and guests.
Figure 35: Copper imido diacetic acid azacrown receptor 53a and the suggested His-Lys binding motif; a copper ...
Figure 36: Urea (54) and thiourea (55) benzo crown receptor for transport and extraction of amino acids.
Figure 37: Crown pyryliums ion receptors 56 for amino acids.
Figure 38: Ditopic sulfonamide bridged crown ether receptor 57.
Figure 39: Luminescent peptide receptor 58.
Figure 40: Luminescent receptor 59 for the detection of D-glucosamine hydrochloride in water/ethanol and lumin...
Figure 41: Guanidinium azacrown receptor 61 for simple amino acids and ditopic receptor 62 with crown ether an...
Figure 42: Chiral bicyclic guanidinium azacrown receptor 63 and similar receptor 64 for the enantioselective t...
Figure 43: Receptors for zwitterionic species based on luminescent CEAAs.
Figure 44: 1,10-Azacrown ethers with sugar podand arms and the anticancer agent busulfan.
Figure 45: Benzo-18-crown-6 modified β-cyclodextrin 69 and β-cyclodextrin functionalized with diaza-18-crown-6...
Figure 46: Receptors for colorimetric detection of primary and secondary ammonium ions.
Figure 47: Porphyrine-crown-receptors 72.
Figure 48: Porphyrin-crown ether conjugate 73 and fullerene-ammonium ion guest 74.
Figure 49: Calix[4]arene (75a), homooxocalix[4]arene (75b) and resorcin[4]arene (75c) compared (R = H, alkyl c...
Figure 50: Calix[4]arene and ammonium ion guest (R = H, alkyl, OAcyl etc.), possible binding sites; A: co-ordi...
Figure 51: Typical guests for studies with calixarenes and related molecules.
Figure 52: Lower rim modified p-tert-butylcalix[5]arenes 82.
Figure 53: The first example of a water soluble calixarene.
Figure 54: Sulfonated water soluble calix[n]arenes that bind ammonium ions.
Figure 55: Displacement assay for acetylcholine (3) with a sulfonato-calix[6]arene (84b).
Figure 56: Amino acid inclusion in p-sulfonatocalix[4]arene (84a).
Figure 57: Calixarene receptor family 86 with upper and lower rim functionalization.
Figure 58: Calix[6]arenes 87 with one carboxylic acid functionality.
Figure 59: Sulfonated calix[n]arenes with mono-substitution at the lower rim systematically studied on their r...
Figure 60: Cyclotetrachromotropylene host (91) and its binding to lysine (81c).
Figure 61: Calixarenes 92 and 93 with phosphonic acids groups.
Figure 62: Calix[4]arene tetraphosphonic acid (94a) and a double bridged analogue (94b).
Figure 63: Calix[4]arene tetraphosphonic acid ester (92c) for surface recognition experiments.
Figure 64: Calixarene receptors 95 with α-aminophosphonate groups.
Figure 65: A bridged homocalix[3]arene 95 and a distally bridged homocalix[4]crown 96.
Figure 66: Homocalix[3]arene ammonium ion receptor 97a and the Reichardt’s dye (97b) for colorimetric assays.
Figure 67: Chromogenic diazo-bridged calix[4]arene 98.
Figure 68: Calixarene receptor 99 by Huang et al.
Figure 69: Calixarenes 100 reported by Parisi et al.
Figure 70: Guest molecules for inclusion in calixarenes 100: DAP × 2 HCl (101a), APA (101b) and Lys-OMe × 2 HC...
Figure 71: Different N-linked peptido-calixarenes open and with glycol chain bridges.
Figure 72: (S)-1,1′-Bi-2-naphthol calixarene derivative 104 published by Kubo et al.
Figure 73: A chiral ammonium-ion receptor 105 based on the calix[4]arene skeleton.
Figure 74: R-/S-phenylalaninol functionalized calix[6]arenes 106a and 106b.
Figure 75: Capped homocalix[3]arene ammonium ion receptor 107.
Figure 76: Two C3 symmetric capped calix[6]arenes 108 and 109.
Figure 77: Phosphorous-containing rigidified calix[6]arene 110.
Figure 78: Calix[6]azacryptand 111.
Figure 79: Further substituted calix[6]azacryptands 112.
Figure 80: Resorcin[4]arene (75c) and the cavitands (113).
Figure 81: Tetrasulfonatomethylcalix[4]resorcinarene (114).
Figure 82: Resorcin[4]arenes (115a/b) and pyrogallo[4]arenes (115c, 116).
Figure 83: Displacement assay for acetylcholine (3) with tetracyanoresorcin[4]arene (117).
Figure 84: Tetramethoxy resorcinarene mono-crown-5 (118).
Figure 85: Components of a resorcinarene based displacement assay for ammonium ions.
Figure 86: Chiral basket resorcin[4]arenas 121.
Figure 87: Resorcinarenes with deeper cavitand structure (122).
Figure 88: Resorcinarene with partially open deeper cavitand structure (123).
Figure 89: Water-stabilized deep cavitands with partially structure (124, 125).
Figure 90: Charged cavitands 126 for tetralkylammonium ions.
Figure 91: Ditopic calix[4]arene receptor 127 capped with glycol chains.
Figure 92: A calix[5]arene dimer for diammonium salt recognition.
Figure 93: Calixarene parts 92c and 129 for the formation molecular capsules.
Figure 94: Encapsulation of a quaternary ammonium cation by two resorcin[4]arene molecules (NMe4+@[75c]2 × Cl−...
Figure 95: Encapsulation of a quaternary ammonium cation by six resorcin[4]arene molecules (NMe3D+@[130]6 × Cl−...
Figure 96: Structure and schematic of cucurbit[6]uril (CB[6], 131a).
Figure 97: Cyclohexanocucurbit[6]uril (CB′[6], 132) and the guest molecule spermine (133).
Figure 98: α,α,δ,δ-Tetramethylcucurbit[6]uril (134).
Figure 99: Structure of the cucurbituril-phthalhydrazide analogue 135.
Figure 100: Organic cavities for the displacement assay for amine differentiation.
Figure 101: Displacement assay methodology for diammonium- and related guests involving cucurbiturils and some ...
Figure 102: Nor-seco-Cucurbituril (±)-bis-ns-CB[6] (140) and guest molecules.
Figure 103: The cucurbit[6]uril based complexes 141 for chiral discrimination.
Figure 104: Cucurbit[7]uril (131c) and its ferrocene guests (142) opposed.
Figure 105: Cucurbit[7]uril (131c) guest inclusion and representative guests.
Figure 106: Cucurbit[7]uril (131c) binding to succinylcholine (145) and different bis-ammonium and bis-phosphon...
Figure 107: Paraquat-cucurbit[8]uril complex 149.
Figure 108: Gluconuril-based ammonium receptors 150.
Figure 109: Examples of clefts (151a), tweezers (151b, 151c, 151d) and clips (151e).
Figure 110: Kemp’s triacid (152a), on example of Rebek’s receptors (152b) and guests.
Figure 111: Amino acid receptor (154) by Rebek et al.
Figure 112: Hexagonal lattice designed hosts by Bell et al.
Figure 113: Bell’s amidinium receptor (156) and the amidinium ion (157).
Figure 114: Aromatic phosphonic acids.
Figure 115: Xylene phosphonates 159 and 160a/b for recognition of amines and amino alcohols.
Figure 116: Bisphosphonate recognition motif 161 for a colorimetric assay with alizarin complexone (163) for ca...
Figure 117: Bisphosphonate/phosphate clip 164 and bisphosphonate cleft 165.
Figure 118: N-Methylpyrazine 166a, N-methylnicotinamide iodide (166b) and NAD+ (166c).
Figure 119: Bisphosphate cavitands.
Figure 120: Bisphosphonate 167 of Schrader and Finocchiaro.
Figure 121: Tweezer 168 for noradrenaline (80b).
Figure 122: Different tripods and heparin (170).
Figure 123: Squaramide based receptors 172.
Figure 124: Cage like NH4+ receptor 173 of Kim et al.
Figure 125: Ammonium receptors 174 of Chin et al.
Figure 126: 2-Oxazolin-based ammonium receptors 175a–d and 176 by Ahn et al.
Figure 127: Racemic guest molecules 177.
Figure 128: Tripods based on a imidazole containing macrocycle (178) and the guest molecules employed in the st...
Figure 129: Ammonium ion receptor 180.
Figure 130: Tetraoxa[3.3.3.3]paracyclophanes 181 and a cyclophanic tetraester (182).
Figure 131: Peptidic bridged paraquat-cyclophane.
Figure 132: Shape-selective noradrenaline host.
Figure 133: Receptor 185 for binding of noradrenaline on surface layers from Schrader et al.
Figure 134: Tetraphosphonate receptor for binding of noradrenaline.
Figure 135: Tetraphosphonate 187 of Schrader and Finocchiaro.
Figure 136: Zinc-Porphyrin ammonium-ion receptors 188 and 189 of Mizutani et al.
Figure 137: Zinc porphyrin receptor 190.
Figure 138: Zinc porphyrin receptors 191 capable of amino acid binding.
Figure 139: Zinc-porphyrins with amino acid side chains for stereoinduction.
Figure 140: Bis-zinc-bis-porphyrin based on Tröger’s base 193.
Figure 141: BINAP-zinc-prophyrin derivative 194 and it’s guests.
Figure 142: Bisaryl-linked-zinc-porphyrin receptors.
Figure 143: Bis-zinc-porphyrin 199 for diamine recognition and guests.
Figure 144: Bis-zinc-porphyrin crown ether 201.
Figure 145: Bis-zinc-porphyrin 202 for stereodiscrimination (L = large substituent; S = small substituent).
Figure 146: Bis-zinc-porphyrin[3]rotaxane and its copper complex and guests.
Figure 147: Dien-bipyridyl ligand 206 for co-ordination of two metal atoms.
Figure 148: The ligand and corresponding tetradentate co-complex 207 serving as enantioselective receptor for a...
Figure 149: Bis(oxazoline)–copper(II) complex 208 for the recognition of amino acids in aqueous solution.
Figure 150: Zinc-salen-complexes 209 for the recognition tertiary amines.
Figure 151: Bis(oxazoline)–copper(II) 211 for the recognition of amino acids in aqueous solution.
Figure 152: Zn(II)-complex of a C2 terpyridine crown ether.
Figure 153: Displacement assay and receptor for aspartate over glutamate.
Figure 154: Chiral complex 214 for a colorimetric displacement assay for amino acids.
Figure 155: Metal complex receptor 215 with tripeptide side arms.
Figure 156: A sandwich complex 216 and its displaceable dye 217.
Figure 157: Lanthanide complexes 218–220 for amino acid recognition.
Figure 158: Nonactin (221), valinomycin (222) and vancomycin (223).
Figure 159: Monesin (224a) and a chiral analogue for enantiodiscrimination of ammonium guests (224b).
Figure 160: Chiral podands (226) compared to pentaglyme-dimethylether (225) and 18-crown-6 (4).
Figure 161: Lasalocid A (228).
Figure 162: Lasalocid derivatives (230) of Sessler et al.
Figure 163: The Coporphyrin I tetraanion (231).
Figure 164: Linear and cyclic peptides for ammonium ion recognition.
Figure 165: Cyclic and bicyclic depsipeptides for ammonium ion recognition.
Figure 166: α-Cyclodextrin (136a) and novocaine (236).
Figure 167: Helical diol receptor 237 by Reetz and Sostmann.
Figure 168: Ammonium binding spherand by Cram et al. (238a) and the cyclic[6]metaphenylacetylene 238b in compar...
Figure 169: Receptor for peptide backbone and ammonium binding (239).
Figure 170: Anion sensor principle with 3-hydroxy-2-naphthanilide of Jiang et al.
Figure 171: 7-bromo-3-hydroxy-N-(2-hydroxyphenyl)naphthalene 2-carboxamide (241) and its amine binding.
Figure 172: Naturally occurring catechins with affinity to quaternary ammonium ions.
Figure 173: Spiropyran (244) and merocyanine form (244a) of the amino acid receptors of Fuji et al.
Figure 174: Coumarin aldehyde (245) and its iminium species with amino acid bound (245a) by Glass et al.
Figure 175: Coumarin aldehyde appended with boronic acid.
Figure 176: Quinolone aldehyde dimers by Glass et al.
Figure 177: Chromogenic ammonium ion receptors with trifluoroacetophenone recognition motifs.
Figure 178: Chromogenic ammonium ion receptor with trifluoroacetophenone recognition motif bound on different m...
Beilstein J. Org. Chem. 2010, 6, No. 15, doi:10.3762/bjoc.6.15
Graphical Abstract
Scheme 1: Synthesis of bis-carbamate 12 and oxazolidinone 13.
Scheme 2: Mechanism of the palladium-catalyzed ionization/cyclization reaction.
Scheme 3: Synthesis of aminocyclitol analogue 6.
Figure 1: The thermal ellipsoid plot of the single crystal X-ray crystallographic structure of 18.
Scheme 4: Synthesis of oxazolidone 23.
Scheme 5: Mechanism of the palladium-catalyzed ionization/cyclization reaction in dichloro biscarbamate 22.
Scheme 6: Synthesis of dichloroaminocyclitol 7.
Figure 2: 1H NMR NOE spectrum of compound 7.
Beilstein J. Org. Chem. 2009, 5, No. 54, doi:10.3762/bjoc.5.54
Graphical Abstract
Figure 1: Molecular structure of NIRPAC: a Pd(II) complex based on Nile red and a curcumin derivative.
Figure 2: Molecular structure of Pd(II) complexes based on functionalised 2-phenylquinolines and β-diketonate...
Figure 3: Some unusual palladiomesogens based on 3,5-disubstituted-2,2′-pyridylpyrroles and β-diketonates.
Figure 4: Molecular structure of Pt(II) complexes based on 4,4′-disubstituted 2,2′-bipyridines.
Figure 5: Molecular structure of Zn(II) complexes based on polycatenar 4,4′-disubstituted 2,2′-bipyridines.
Figure 6: Molecular structure of a gallium(III) mesogen.
Beilstein J. Org. Chem. 2009, 5, No. 44, doi:10.3762/bjoc.5.44
Graphical Abstract
Scheme 1: Brominations of 6H-1,2-oxazines. a) Br2, Et2O, −30 °C, 2 h. b) Et3N, −30 °C to r.t., overnight.
Scheme 2: Chlorinations of 6H-1,2-oxazines. a) Cl2, Et2O, −30 °C. b) Et3N, −30 °C to r.t.
Scheme 3: Suzuki-couplings of 4-bromo-6H-1,2-oxazines. a) ArB(OH)2, Pd(PPh3)4, Na2CO3, toluene, 80 °C, 3 h.
Scheme 4: Sonogashira-couplings of 4-bromo-6H-1,2-oxazines. a) PdCl2(PPh3)2, CuI, Et3N, toluene, r.t., 6–20 h....
Scheme 5: Sonogashira-couplings of 4,5-dibromo-6H-1,2-oxazines. a) PdCl2(PPh3)2, CuI, Et3N, toluene, r.t., 4 ...
Scheme 6: Preparation of trisubstituted pyridine derivatives: a) BF3·OEt2, CH2Cl2, −78 °C to r.t., overnight.